SQZ Biotechnologies (NYSE:SQZ) Expected to Post Quarterly Sales of $4.17 Million
Wall Street brokerages expect SQZ Biotechnologies (NYSE:SQZ – Get Rating) to post $4.17 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for SQZ Biotechnologies’ earnings, with estimates ranging from $3.00 million to $4.92 million. SQZ Biotechnologies posted sales of $4.54 million in the same quarter last […]